2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R. Haugen,Erik K. Alexander,Keith C. Bible,Gerard M. Doherty,Susan J. Mandel,Yuri E. Nikiforov,Furio Pacini,Gregory W. Randolph,Anna M. Sawka,Martin Schlumberger,Kathryn G. Schuff,Steven I. Sherman,Julie Ann Sosa,David L. Steward,R. Michael Tuttle,Leonard Wartofsky +15 more
TLDR
Evidence-based recommendations are developed to inform clinical decision-making in the management of thyroid nodules and differentiated thyroid cancer and represent, in the authors' opinion, contemporary optimal care for patients with these disorders.Abstract:
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Since the American Thyroid Association's (ATA's) guidelines for the management of these disorders were revised in 2009, significant scientific advances have occurred in the field. The aim of these guidelines is to inform clinicians, patients, researchers, and health policy makers on published evidence relating to the diagnosis and management of thyroid nodules and differentiated thyroid cancer. Methods: The specific clinical questions addressed in these guidelines were based on prior versions of the guidelines, stakeholder input, and input of task force members. Task force panel members were educated on knowledge synthesis methods, including electronic database searching, review and selection of relevant citations, and critical appraisal of selected studies. Published English language articles on adults were eligible for inclusion. The American College of Physicians Guideline Gr...read more
Citations
More filters
Journal ArticleDOI
International neural monitoring study group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal
Rick Schneider,Gregory W. Randolph,Gregory W. Randolph,Gianlorenzo Dionigi,Che-Wei Wu,Marcin Barczyński,Feng-Yu Chiang,Zaid Al-Quaryshi,Peter Angelos,Katrin Brauckhoff,Claudio Roberto Cernea,John M. Chaplin,Jonathan Cheetham,Louise Davies,Peter E. Goretzki,Dana M. Hartl,Dipti Kamani,Emad Kandil,Natalia Kyriazidis,Whitney Liddy,Lisa A. Orloff,Joseph Scharpf,Jonathan W. Serpell,Jonathan W. Serpell,Jennifer J. Shin,Catherine F. Sinclair,Michael C. Singer,Samuel K. Snyder,Neil Tolley,Sam Van Slycke,Erivelto Volpi,Ian J. Witterick,Richard J. Wong,Gayle E. Woodson,Mark Zafereo,Henning Dralle +35 more
TL;DR: This publication offers modern, state‐of‐the‐art International Neural Monitoring Study Group guidelines based on a detailed review of the recent monitoring literature, designed to reduce technique variations, enhance the quality of neural monitoring, and assist surgeons in the clinical decision‐making process involved in surgical management of recurrent laryngeal nerve.
Journal ArticleDOI
Prevalence of Differentiated Thyroid Cancer in Autopsy Studies Over Six Decades: A Meta-Analysis
TL;DR: It is confirmed that iDTC is common, but the observed increasing incidence is not mirrored by prevalence within autopsy studies and, therefore, is unlikely to reflect a true population-level increase in tumorigenesis.
Journal ArticleDOI
Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma
Raj K. Gopal,K Kübler,K Kübler,Sarah E. Calvo,Sarah E. Calvo,Sarah E. Calvo,Paz Polak,Dimitri Livitz,Daniel Rosebrock,Peter M. Sadow,Braidie Campbell,Samuel E. Donovan,Salma Amin,Benjamin J. Gigliotti,Zenon Grabarek,Zenon Grabarek,Zenon Grabarek,Julian M. Hess,Chip Stewart,Lior Z. Braunstein,Peter F. Arndt,Scott Mordecai,Angela R. Shih,Frances L Chaves,Tiannan Zhan,Carrie C. Lubitz,Jiwoong Kim,A. John Iafrate,Lori J. Wirth,Sareh Parangi,Ignaty Leshchiner,Gilbert H. Daniels,Vamsi K. Mootha,Dora Dias-Santagata,Gad Getz,David G. McFadden +35 more
TL;DR: In this paper, the authors performed whole-exome sequencing on a cohort of primary, recurrent, and metastatic tumors, and identified recurrent mutations in DAXX, TP53, NRAS, NF1, CDKN1A, ARHGAP35, and the TERT promoter.
Journal ArticleDOI
Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
Hyemi Kwon,Hyemi Kwon,Hye-Seon Oh,Mijin Kim,Suyeon Park,Min Ji Jeon,Won Gu Kim,Won Bae Kim,Young Kee Shong,Dong Eun Song,Jung Hwan Baek,Ki-Wook Chung,Tae Yong Kim +12 more
TL;DR: Some PTMCs could grow significantly after a relatively short period of active surveillance, and the change in tumor volume was more sensitive to detect tumor progression than thechange in the maximal tumor diameter.
Journal ArticleDOI
Novel targeted therapies and immunotherapy for advanced thyroid cancers
TL;DR: The molecular escape mechanisms of thyroid tumors from these drugs are discussed, and novel therapeutic options targeting other pathways than MAPK, including PI3K pathway, ALK translocations and HER2/3 receptors and their clinical impact are highlighted.
References
More filters
Journal ArticleDOI
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
Elizabeth Eisenhauer,P. Therasse,Jan Bogaerts,Lawrence H. Schwartz,Daniel J. Sargent,Robert Ford,Janet Dancey,S. Arbuck,S. Gwyther,Margaret M. Mooney,Larry Rubinstein,Lalitha K. Shankar,Lori E. Dodd,Robert M. Kaplan,Denis Lacombe,Jaap Verweij +15 more
TL;DR: The revised RECIST includes a new imaging appendix with updated recommendations on the optimal anatomical assessment of lesions, and a section on detection of new lesions, including the interpretation of FDG-PET scan assessment is included.
Journal ArticleDOI
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Suzanne L. Topalian,F. Stephen Hodi,Julie R. Brahmer,Scott N. Gettinger,David Smith,David F. McDermott,John D. Powderly,Richard D. Carvajal,Jeffrey A. Sosman,Michael B. Atkins,Philip D. Leming,David R. Spigel,Scott J. Antonia,Leora Horn,Charles G. Drake,Drew M. Pardoll,Lieping Chen,William H. Sharfman,Robert A. Anders,Janis M. Taube,Tracee L. McMiller,Haiying Xu,Alan J. Korman,Maria Jure-Kunkel,Shruti Agrawal,Dan McDonald,Georgia Kollia,Ashok Kumar Gupta,Jon M. Wigginton,Mario Sznol +29 more
TL;DR: Anti-PD-1 antibody produced objective responses in approximately one in four to one in five patients with non-small-cell lung cancer, melanoma, or renal-cell cancer; the adverse-event profile does not appear to preclude its use.
Journal ArticleDOI
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
David S. Cooper,Gerard M. Doherty,Bryan R. Haugen,Richard T. Kloos,Stephanie L. Lee,Susan J. Mandel,Ernest L. Mazzaferri,Bryan McIver,Furio Pacini,Martin Schlumberger,Steven I. Sherman,David L. Steward,R. Michael Tuttle +12 more
TL;DR: Evidence-based recommendations in response to the appointment as an independent task force by the American Thyroid Association to assist in the clinical management of patients with thyroid nodules and differentiated thyroid cancer represent, in the authors' opinion, contemporary optimal care for patients with these disorders.
Journal ArticleDOI
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer,Scott S. Tykodi,Scott S. Tykodi,Laura Q.M. Chow,Wen-Jen Hwu,Suzanne L. Topalian,Patrick Hwu,Charles G. Drake,Luis H. Camacho,John S. Kauh,Kunle Odunsi,Henry C. Pitot,Omid Hamid,Shailender Bhatia,Renato G. Martins,Keith D. Eaton,Shuming Chen,Theresa M. Salay,Suresh Alaparthy,Joseph F. Grosso,Alan J. Korman,Susan M. Parker,Shruti Agrawal,Stacie M. Goldberg,Drew M. Pardoll,Ashok Kumar Gupta,Jon M. Wigginton +26 more
TL;DR: Antibody-mediated blockade of PD-L1 induced durable tumor regression and prolonged stabilization of disease in patients with advanced cancers, including non-small-cell lung cancer, melanoma, and renal-cell cancer.
Journal ArticleDOI
Decision aids for people facing health treatment or screening decisions
Dawn Stacey,Dawn Stacey,Krystina B. Lewis,Michael J. Barry,Carol Bennett,Karen Eden,Margaret Holmes-Rovner,Hilary A. Llewellyn-Thomas,Anne Lyddiatt,Richard Thomson,Lyndal Trevena +10 more
TL;DR: Decision aids reduced the proportion of undecided participants and appeared to have a positive effect on patient-clinician communication, and those exposed to a decision aid were either equally or more satisfied with their decision, the decision-making process, and the preparation for decision making compared to usual care.
Related Papers (5)
Increasing incidence of thyroid cancer in the United States, 1973-2002.
Louise Davies,H. Gilbert Welch +1 more